ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.45
-0.22 (-2.54%)
At close: Mar 9, 2026, 4:00 PM EDT
8.42
-0.03 (-0.36%)
After-hours: Mar 9, 2026, 6:21 PM EDT
ImmunityBio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | -351.4 | -413.56 | -583.2 | -416.57 | -346.79 | Upgrade
|
| Depreciation & Amortization | 15.43 | 17.55 | 18.51 | 18.26 | 14.24 | Upgrade
|
| Other Amortization | 0.1 | 22.59 | 42.4 | 16.28 | 0.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | 14.02 | - | 0.89 | 2.01 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.75 | -0.86 | 1.45 | 5.51 | 5.02 | Upgrade
|
| Stock-Based Compensation | 36.81 | 34.43 | 49.16 | 40.18 | 57.18 | Upgrade
|
| Other Operating Activities | 37.18 | -31.97 | 100.2 | 4.82 | 14.98 | Upgrade
|
| Change in Accounts Receivable | -40.21 | -2.36 | - | - | - | Upgrade
|
| Change in Inventory | -6.33 | -8.27 | - | - | - | Upgrade
|
| Change in Accounts Payable | -0.19 | -3.17 | -6.48 | 8 | -3.72 | Upgrade
|
| Change in Other Net Operating Assets | -7.6 | -5.62 | 10.3 | -16 | -15.4 | Upgrade
|
| Operating Cash Flow | -304.94 | -391.24 | -366.76 | -337.51 | -274.42 | Upgrade
|
| Capital Expenditures | -3.85 | -6.89 | -30.58 | -78.16 | -33.56 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 20.5 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.41 | - | - | -21.23 | - | Upgrade
|
| Investment in Securities | -145.55 | -5.36 | 0.11 | 126.69 | -71.82 | Upgrade
|
| Investing Cash Flow | -149.8 | -12.25 | -30.47 | 27.3 | -84.89 | Upgrade
|
| Short-Term Debt Issued | 2.88 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 96.96 | 451.46 | 174.13 | 338.5 | Upgrade
|
| Total Debt Issued | 2.88 | 96.96 | 451.46 | 174.13 | 338.5 | Upgrade
|
| Long-Term Debt Repaid | -1.16 | -0.06 | -0.08 | -0.06 | - | Upgrade
|
| Net Debt Issued (Repaid) | 1.72 | 96.89 | 451.39 | 174.07 | 338.5 | Upgrade
|
| Issuance of Common Stock | 400.78 | 190.2 | 100.86 | 60.5 | 169.99 | Upgrade
|
| Repurchase of Common Stock | -2.27 | -5.47 | -3.44 | -0.62 | -4.06 | Upgrade
|
| Other Financing Activities | - | - | 9.54 | -0.34 | 1.02 | Upgrade
|
| Financing Cash Flow | 400.24 | 281.63 | 558.34 | 233.61 | 505.44 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | -0.02 | -0.29 | 0.28 | 0.05 | Upgrade
|
| Net Cash Flow | -54.48 | -121.88 | 160.82 | -76.32 | 146.19 | Upgrade
|
| Free Cash Flow | -308.78 | -398.12 | -397.34 | -415.67 | -307.98 | Upgrade
|
| Free Cash Flow Margin | -272.56% | -2700.06% | -63881.19% | -173196.25% | -32974.52% | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.57 | -0.78 | -1.04 | -0.79 | Upgrade
|
| Cash Interest Paid | 71.32 | 92.32 | 77.19 | 35.44 | 2.11 | Upgrade
|
| Cash Income Tax Paid | - | 0.02 | 0.01 | 0 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -213.36 | -256.31 | -234.66 | -299.03 | -170.3 | Upgrade
|
| Unlevered Free Cash Flow | -143.03 | -182.44 | -196.31 | -275.62 | -161.08 | Upgrade
|
| Change in Working Capital | -54.33 | -19.42 | 3.83 | -8 | -19.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.